Effect of Tailored vs Standard use of the Combined Oral Contraceptive on Continuation Rates at one year.
Phase of Trial: Phase IV
Latest Information Update: 11 Apr 2013
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- 25 Oct 2012 Investigational drug identified as Ethinylestradiol/levonorgestrel as reported by European Clinical Trials Database.
- 31 May 2012 Additional location (Scotland) added as reported by United Kingdom Clinical Research Network record.
- 19 Nov 2010 United Kingdom Clinical Research Network reports accrual to date changed from 73% to 85%.